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Obesity and its comorbidity incidence have increased worldwide during
the past 10 years. In consequence, researchers have drawn their attention
to the understanding of adipocyte differentiation. Several cellular model
systems have been established; however no efﬁcient protocol could be
developed so far to differentiate the pluripotent embryonic stem cells to
adipocytes. In this chapter, we describe a detailed protocol that is
optimized for mouse embryonic stem cells. The result of this
differentiation is a homogenous adipocyte monolayer culture that can be
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7Abstract
8Obesity and its comorbidity incidence have increased worldwide during the past 10 years. In consequence,
9researchers have drawn their attention to the understanding of adipocyte differentiation. Several cellular
10model systems have been established; however no efficient protocol could be developed so far to differentiate
11the pluripotent embryonic stem cells to adipocytes. In this chapter, we describe a detailed protocol that is
12optimized for mouse embryonic stem cells. The result of this differentiation is a homogenous adipocyte
13monolayer culture that can be used for several applications including developmental and pharmacological
14research.
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161 Introduction
17Obesity has become a public health issue worldwide due to the
18increasing incidence and prevalence of overweight patients and
19related comorbidities. In the USA 39 % of the population is
20obese (1). These obesity-linked diseases affect quality of life and
21increase mortality rate in the affected population (2, 3). Therefore,
22understanding adipocyte differentiation regulation has drawn the
23interest of researchers. Two phases of fat cell differentiation process
24can be distinguished: (1) determination phase, which includes the
25stem cell differentiation to a preadipocyte stage, and (2) terminal
26differentiation phase that involves the events of the differentiation
27from preadipocyte to adipocytes (4). There are various models for
28adipocyte differentiation that focus in the terminal differentiation
29stage (4, 5). However, the ideal model system for adipocyte differ-
30entiation would encompass both the early and the late stages. In
31theory, somatic stem cells and pluripotent stem cells can be used for
32this purpose (6). It had been shown that these cells can differentiate
33into all three embryonic layers (7). The principal problem of this
34model system is the low efficiency of the adipocyte differentiation
35and heterogeneity of the culture (8–10). We recently described
36that with the addition of ascorbic acid one can overcomes these
37issues (11) and here we present a step-by-step protocol with
38detailed instructions and notes. The adipocytes differentiated
39from embryonic stem cells using this protocol can be used for
40various aims including transcriptomic, proteomic studies and
41provide a novel model system for pharmacological research.
422 Materials
431. mESC medium: Dulbecco’s modified essential medium
44(DMEM) with GlutaMAX (Gibco, 31966-021) supplemented
45with 15 % of Hyclone FBS (Thermo, SH30070.03), 100
46Non-Essential Amino Acid solution (Sigma, M7145), 100
47Penicillin/Streptomycin (PAA, P11-010), 0.1 mM
482-mercaptoethanol (Sigma,M3148), and 1,000U of Leukemia
49Inhibitory Factor (Millipore, ESG1107) (see Note 1).
502. Differentiation medium: DMEM with GlutaMAX (Gibco,
5131966-021) supplemented with 10 % of Hyclone FBS
52(Thermo, SH30070.03), 100 Non-Essential Amino Acid
53solution (Sigma, M7145), 100 Penicillin/Streptomycin
54(PAA, P11-010) (see Note 1).
553. Feeder’s medium: DMEM (Sigma, D5671) supplemented with
5610 % of FBS, 100 Penicillin/Streptomycin (PAA, P11-010),
57100 L-glutamine (PAA, M11-004).
584. Feeder’s freezing medium: 1:1 ratio of feeder’s medium and
59DMEM (Sigma, D5671) supplemented with 20 % of cell
60culture-tested FBS and 5 % DMSO.
615. 0.05 % Trypsin-EDTA (Gibco, 25300-054) (see Note 2).
626. Primary mouse embryonic fibroblasts (PMEFs), mitomycin C
63treated: PMEFs are routinely isolated from 13.5-day-old
64mouse embryos (strain: C57BL/6 or CD-1). Isolated cells are
65cultured in 150 mm culture dishes and expanded by passaging
66them up to two times in a dilution 1:4. Before freezing, the cells
67are treated with 10 ng/mL mitomycin C (Sigma, M0503) for
683.5 h. After the mitomycin C treatment the PMEFs are washed
69twice with PBS and trypsinized. The cellular suspension is
70centrifuged for 325  g and resuspended in feeder’s freezing
71medium and aliquoted by adding 600,000 cells in each cryovial
72(see Note 3). PMEFs mitomycin C treated are also commer-
73cially available (Millipore, PMEF-CF).
747. Mouse embryonic stem cells: The described protocol has been
75optimized to E14 cells. Modified E14 cell lines are commer-
76cially available (ATCC® CRL-1821™).
778. Dimethyl-sulfoxide (DMSO) (Sigma, D5879).
789. Methanol (Analar NORMAPUR, 20847.295).
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7910. Absolute Ethanol (Analar NORMAPUR, 20821.296).
8011. Sterile nuclease-free water (NFW).
8112. All-trans retinoic acid (ATRA) (Sigma, R2625): Prepare a
821 mM stock in DMSO, keep in the dark, and store it at20 C.
8313. L-Ascorbic acid (AsA) (Sigma, A4403) 12.5 and 25 mg/mL
84stock in NFW: Store it at 20 C up to 1 month, keeping it in
85dark conditions (see Note 4).
8614. Rosiglitazone (Selleckchem, S2505): Prepare 1 mM stock in
87DMSO:ethanol.
8815. 3-Isobutyl-1-methylxanthine (IBMX) (Sigma, I5879) 0.5 M
89stock in DMSO:ethanol (see Note 5).
9016. Insulin solution 10 mg/mL (Sigma, I9278): Dilute it in differ-
91entiation medium to 1 mg/mL.
9217. Phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM
93KCl, 8 mM Na2HPO4, and 1.46 mM KH2PO4).
9418. 3,30,5-Triiodo-L-thyronine sodium salt (T3) (Sigma, T6397):
95Prepare a 3 μM stock in differentiation medium, and aliquot it
96to avoid freeze-thaw cycles.
9719. Dexamethasone (Sigma, D4902) 0.1 mM stock in ethanol: It is
98very stable at 20 C.
9920. Indomethacin (Sigma, I7378) 30 mM stock in methanol: Can
100be stored at 4 C up to 1 month.
10121. Accutase (PAA, L11-007).
10222. Sterile gelatin, 0.1 %.
10323. Cell culture dishes 100 mm, 150 mm (Greiner Bio-One,
104664160 and 639160, respectively) and 6-well plates (TPP,
105TPPA92006).
10624. Cell Strainer, 40 μm (BD Bioscience, 352340).
10725. Bacteriological grade dishes 150 mm (SARSTEDT, 82.1184).
10826. 15 and 50 mL conical sterile tubes.
10927. 10 mL pipette tips.
1103 Methods
111All procedures should be done under sterile conditions using
112aseptic techniques. Appropriated cell culture hood should be
113used. All centrifugations are carried out at 325  g during 5 min.
114Standard 37 C humidified 5 % CO2 incubator is needed.
3.1 mES Cell Culture 1151. Prepare gelatinized plates for PMEFs. Add 1 mL 0.1 % gelatin
116to 2 wells of a 6-well plate. Incubate at least for 30 min at 37 C
117in humidified incubator (see Note 6). Thaw one cryovial of
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118PMEFs, and immediately remove the freezing medium
119containing DMSO by centrifugation. Resuspend the cell pellet
120in feeder’s medium and plate them into the previously gelati-
121nized wells after removing the gelatine (see Note 7).
1222. 12 or 24 h after preparing the feeder’s monolayer thaw
1231,000,000 mES cells. To remove DMSO freezing medium
124transfer the content of the cryovial into a 15 mL centrifuge
125tube containing 4.5 mL mESC medium and centrifuge the
126cells. Resuspend gently the cell pellet in 4 mL fresh mESC
127medium and plate the cells in the 2 wells containing mitomycin
128C-treated PMEFs (see Note 8). Change medium daily using
129mESC medium.
1303. Under these conditions the cells should be ready to use after 3
131days in culture. The mES cells should reach 70–80 %
132confluency (Fig. 1a).
133
3.2 mES Cell Feeder
Depletion
1341. As a first step of differentiation split the culture in 1:5 ratio in
135feeder-free condition. First, wash once the cells with PBS, add
136trypsin, and incubate for 3–5 min in the incubator. Add mESC
137medium to inactivate the trypsin and dissociate the stem cell
138clumps until single-cell suspension is achieved. Then split in 1:5
139ratio (see Note 9). Change mESC medium daily. The feeder-
140free stem cells change their morphology (Fig. 1b) but they keep
141their high capacity of cell proliferation.
1422. After 2 days of culture the feeder-free mES cells can be pas-
143saged. Repeat the feeder-free passage two times more. As the
144last two feeder-free passages can be done in 1:10 or 1:15







1481. The feeder-free stem cells are trypsinized. The cellular suspen-
149sion should be counted and diluted for EB formation. Briefly,
150before adding trypsin to the cell culture wash once with PBS.
151The trypsin is inactivated by 4mL differentiation medium per 1
152well of 6-well plate (see Note 11). Count the total cell number
153and prepare a cell suspension by diluting the cells in differenti-
154ation medium to 1  105 cells/mL. Prepare the bottom of
155150 mm bacteriological Petri dish by adding 15 mL PBS and
156100 μL differentiation medium. The latter step will decrease
157the surface tension of the liquid. Finally, place 20 μL drops of
158the 1  105 cells/mL suspension onto the inner surface of the
159lids of bacteriological grade dishes with a multichannel pipette.
160This step is referred as “Adipocyte differentiation Day 0”
161(Fig. 1c). Invert the lid over the bottom of the bacteriological
162Petri dish and place it very carefully in the incubator.























































100 µL Diff medium
Day
Fig. 1 Stepwise adipocyte differentiation protocol from mouse embryonic stem cells. (a–k) is a representative
picture of the steps mentioned in the text
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1632. After 2 days the EBs are collected. Slowly remove the lid of the
164bacteriological plates, invert it, and wash the lids with 10 mL
165PBS to collect the EBs into a 50 mL conical sterile tube.
166Remove the medium by allowing EBs to sediment for
16710–20 min at room temperature (day 2, Fig. 1d). Aspirate the
168PBS and resuspend the EBs in differentiation medium.
169The EBs obtained from one lid can be plated in 1 well of
170gelatin-precoated 6-well plate in 1 mL differentiation medium






1731. One day after plating the EBs (at day 3), change differentiation
174medium containing only 1 μM ATRA and 12.5 μg/mL AsA in
175final concentration and change medium every day (Fig. 1e)
176(see Note 13).
1772. Three days after starting the ATRA treatment (day 6, Fig. 1f)
178remove ATRA from the medium. Table 1 contains a summary
179of medium and supplements used along the differentiation.
1803. Next day (day 7, Fig. 1g), change the differentiation medium
181by adding the freshly prepared hormonal cocktail: AsA
182(12.5 μg/mL), T3 (3 nM), insulin (0.5 μg/mL), and
t:1 Table 1
Summary of medium and adipogenic cocktails in mES adipocyte differentiation
Days of differentiation Medium Supplemented witht:2
Until day 0 mESC medium LIFt:3
Day 0 to day 3 Differentiation mediumt:4
Day 3 to day 6 Differentiation medium ATRA 1 μM
AsA 12.5 μg/mLt:5
Day 6 to day 7 Differentiation medium AsA 12.5 μg/mLt:6














t:10 Leukemia inhibitory factor (LIF), All-trans retinoic acid (ATRA), Ascorbic acid (AsA)
aThe addition of rosiglitazone is optional; see Note 14 for details
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183rosiglitazone (0.5 μM). Change this medium daily; prepare
184every day freshly from stock solutions. The addition of rosigli-
185tazone is optional (see Note 14).
1864. At day 12 of adipocyte differentiation (Fig. 1h) disperse the
187cells by 1 mL accutase. Before the enzymatic digestion wash the
188culture with PBS once. Incubate the cells with accutase for
18920–25min in the incubator. Add 2mL differentiationmedium,
190resuspend thoroughly, and place the cellular suspension in a
19150 mL sterile conical tube. Finally wash each well with 2 mL
192differentiation medium and collect it on the same tube
193(seeNote 15). Plate the cells in differentiation medium supple-
194mented with AsA (12.5 μg/mL), rosiglitazone (0.5 μM),
195insulin (0.5 μg/mL), and T3 (3 nM) (see Note 16).
1965. Do not change the medium between days 12 and 15 of the
197differentiation.
1986. After day 15 (Fig. 1i) change medium every 3 days supplemen-
199ted with AsA (25 μg/mL), dexamethasone (0.1 μM), insulin
200(20 μg/mL), rosiglitazone (0.5 μM), indomethacin
201(0.06 mM), and IBMX (0.5 mM). The addition of rosiglita-
202zone is optional (see Note 14).
2037. At day 21 of adipocyte differentiation (Fig. 1j) and day 24
204change differentiation medium containing AsA (25 μg/mL),
205insulin (20 μg/mL), rosiglitazone (0.5 μM), and T3 (3 nM).
206The addition of rosiglitazone is optional (see Note 14).
2078. Assess the cultures for the presence of lipid droplet containing
208adipocytes at day 27 (Fig. 1k) (see Note 17).
209
2104 Notes
2111. The quality of the medium and serum used during the stem cell
212culture is a crucial factor for the differentiation process.
213We recommend using the mentioned medium and serum for
214culturing the stem cells and for the differentiation. If another
215medium or serum would be used it is very important not only
216to assess the morphology of the stem cells during expansion but
217also the ability to form EBs and differentiate. LIF should be
218added to the medium freshly or the mESC medium containing
219LIF should be used preferably within 3 days.
2202. Either for expansion or EB formation, after chemical disruption
221of the stem cell culture the cells should be in a single-cell suspen-
222sion. In our experience not all the brands of trypsin achieve this
223and we recommend the 0.05 % trypsin mentioned in Section 2.
2243. The freezing medium for the mitomycin-treated PMEFs is
225important for their survival. Also the freezedmitomycin-treated
226PMEFs should be shortly collocated in liquid nitrogen (within 1
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227or 2 days after freezing) for longer term storage. PMEFs should
228be tested for mycoplasma in case of each new preparation.
2294. Ascorbic acid stock should not be used after 1 month of stor-
230age. It is a light-sensitive compound. It is recommended to
231prepare a new stock for each differentiation process. Similar
232results were obtained using sodium L-ascorbate (A4034) and
233L-ascorbic acid 2-phosphate sesquimagnesium salt (Sigma,
234A8960).
2355. DMSO can inhibit the adipocyte differentiation; therefore
236concentrated stocks are recommended. IBMX 0.5 M stock
237can be difficult to resuspend; it is advisable to heat it in the
23837 C water bath until the solution is completely homogeneous
239and store it in aliquots to avoid repeated freeze-thaw cycles.
2406. Gelatin 0.1 % incubation times less than 30 min before plating
241PMEFs can lead to suboptimal attaching ratio of mitomycin-
242treated PMEFs.
2437. In our experience 600,000 PMEFs mitomycin C treated can
244perfectly be used in 2 wells of a 6-well plate or in one T-25 flask.
245The cells can be used from 12 h up to 1 week after thawed.
2468. Thawing 1,000,000 mES cells can be done in 2 wells of 6-well
247plate or in one T-25 flask.
2489. The cell culture should be split 1:5 or 1:7 ratio for the first
249passage without feeders. mES cells are sensitive to feeder deple-
250tion; thus higher dilutions could result in stem cell spontaneous
251differentiation.
25210. Other mES cell strains might be sensitive to feeder-free condi-
253tions as for example induced pluripotent stem cells. In such case
254feeder-free passages are not recommended. These stem cells
255should be feeder depleted the day 0 of the differentiation.
256Briefly, after trypsinizing the stem cell culture, the cells are
257incubated in a gelatinized wells or flask for 20–30 min. Pipette
258the cell suspension to a 15 mL centrifuge tube and count the
259cell number. After this step follow the EB formation step.
26011. Single-cell suspension is needed for a reproducible and
261adequate EB formation.
26212. EBs are very sensitive to mechanical manipulation. Use 10 mL
263pipette tips when collecting and plating the EBs. Avoid pipet-
264ting EBs several times.
26513. One-day plated EBs could detach easily; therefore, remove the
266medium with pipette instead of water pump/vacuum suction at
267least in the first 3 days.
26814. Addition of rosiglitazone is optional; it does not significantly
269increase the adipocyte differentiation in stem cells, but can
270produce increased differentiation of Ucp-1+ adipocytes in the
271terminally differentiated cultures (11).
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27215. If the extracellular matrix cannot be disrupted, use a 40 μm
273mesh to remove the clumps.
27416. This protocol offers the advantage that can be used for several
275applications. The cells can be repleted in different dishes andwell-
276plate formats: 100,000 cells per well of a 6-well plate, 50,000
277cells per well of a 24-well plate, 1,000,000 cells per 100mmdish,
278and 1,800,000 cells per 150 mm cell culture dish (11).
27917. The adipocyte cultures, due to their high content of adipocytes,
280and the monolayer culture can be evaluated using standard
281techniques including transcriptome, epigenetic, and immuno-
282staining analysis.
283Acknowledgments
284The authors would like to thank Dr. Gerardo Alvarado for the
285artwork. L.N. is supported by a grant from the Hungarian Scientific
286Research Fund (OTKAK100196). L.N. and I.C-M. are recipients of
287the following grant TA´MOP-4.2.2.A-11/1/KONV-2012-0023
288VE´D-ELEM implemented through theNewHungaryDevelopment
289Plan cofinanced by the European Social Fund and the European
290Regional Development Fund. Z.S. is a recipient of TA´MOP 4.2.4.
291A/2-11-1-2012-0001/A2-JA´DJ-13.
292 References
294 1. Ford ES (2005) Prevalence of the metabolic
295 syndrome defined by the International Diabe-
296 tes Federation among adults in the U.S. Dia-
297 betes Care 28(11):2745–2749
298 2. Unger RH, Clark GO, Scherer PE, Orci L
299 (2010) Lipid homeostasis, lipotoxicity and the
300 metabolic syndrome. Biochim Biophys Acta
301 1801(3):209–214. doi:10.1016/j.bbalip.
302 2009.10.006
303 3. Savage DB, Petersen KF, Shulman GI (2007)
304 Disordered lipid metabolism and the patho-
305 genesis of insulin resistance. Physiol Rev 87
306 (2):507–520. doi:10.1152/physrev.00024.
307 2006
308 4. Rosen ED, MacDougald OA (2006) Adipo-
309 cyte differentiation from the inside out. Nat
310 Rev Mol Cell Biol 7(12):885–896. doi:10.
311 1038/nrm2066
312 5. Choi J, Tontonoz P (2013) Metabolism: drug
313 discovery goes for a swim. Nat Chem Biol 9
314 (2):68–69. doi:10.1038/nchembio.1167
315 6. Takahashi K, Yamanaka S (2006) Induction of
316 pluripotent stem cells from mouse embryonic
317 and adult fibroblast cultures by defined factors.
318 Cell 126(4):663–676
3197. Itskovitz-Eldor J, Schuldiner M, Karsenti D,
320Eden A, Yanuka O, Amit M, Soreq H, Benve-
321nisty N (2000) Differentiation of human
322embryonic stem cells into embryoid bodies
323compromising the three embryonic germ
324layers. Mol Med 6(2):88–95
3258. Dani C, Smith AG, Dessolin S, Leroy P, Stac-
326cini L, Villageois P, Darimont C, Ailhaud G
327(1997) Differentiation of embryonic stem
328cells into adipocytes in vitro. J Cell Sci 110(Pt
32911):1279–1285
3309. Chen TL, Shen WJ, Qiu XW, Li T, Hoffman
331AR, Kraemer FB (2007) Generation of novel
332adipocyte monolayer cultures from embryonic
333stem cells. Stem Cells Dev 16(3):371–380.
334doi:10.1089/scd.2006.0037
33510. Schaedlich K, Knelangen JM, Navarrete Santos
336A, Fischer B, Navarrete Santos A (2010) A
337simple method to sort ESC-derived adipocytes.
338Cytometry A 77(10):990–995
33911. Cuaranta-Monroy I, Simandi Z, Kolostyak Z,
340Doan-Xuan QM, Poliska S, Horvath A, Nagy
341G, Bacso Z, Nagy L (2014) Highly efficient
342differentiation of embryonic stem cells into
343adipocytes by ascorbic acid. Stem Cell Res 13
344(1):88–97. doi:10.1016/j.scr.2014.04.015
mES Cells Adipocyte Differentiation
Author Queries
Chapter No.: 219
Query Refs. Details Required Author’s response
AU1 Please check whether the author affiliations and
corresponding details are presented correctly.
